As of 2026-04-04, the EV/EBITDA ratio of Mediplantex National Pharmaceutical JSC (MED.VN) is 8.91. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MED.VN's latest enterprise value is 262,676.70 mil VND. MED.VN's TTM EBITDA according to its financial statements is 29,489.42 mil VND. Dividing these 2 quantities gives us the above MED.VN EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 7.6x - 10.0x | 8.4x |
| Forward P/E multiples | 5.7x - 8.7x | 7.2x |
| Fair Price | 17,340.57 - 40,557.82 | 26,117.03 |
| Upside | -15.0% - 98.8% | 28.0% |
| Date | EV/EBITDA |
| 2026-03-27 | 8.91 |
| 2026-03-26 | 8.91 |
| 2026-03-25 | 8.91 |
| 2026-03-24 | 8.91 |
| 2026-03-23 | 8.91 |
| 2026-03-20 | 8.91 |
| 2026-03-19 | 8.91 |
| 2026-03-18 | 8.91 |
| 2026-03-17 | 8.91 |
| 2026-03-16 | 8.91 |
| 2026-03-13 | 8.91 |
| 2026-03-12 | 8.91 |
| 2026-03-11 | 8.91 |
| 2026-03-10 | 8.91 |
| 2026-03-09 | 8.91 |
| 2026-03-06 | 8.91 |
| 2026-03-05 | 8.91 |
| 2026-03-04 | 8.91 |
| 2026-03-03 | 8.91 |
| 2026-03-02 | 8.91 |
| 2026-02-27 | 8.91 |
| 2026-02-26 | 8.91 |
| 2026-02-25 | 8.91 |
| 2026-02-24 | 8.91 |
| 2026-02-23 | 8.91 |
| 2026-02-13 | 8.91 |
| 2026-02-12 | 8.91 |
| 2026-02-11 | 8.91 |
| 2026-02-10 | 8.91 |
| 2026-02-09 | 8.91 |
| 2026-02-06 | 8.91 |
| 2026-02-05 | 8.91 |
| 2026-02-04 | 8.91 |
| 2026-02-03 | 8.91 |
| 2026-02-02 | 8.91 |
| 2026-01-30 | 8.91 |
| 2026-01-29 | 9.79 |
| 2026-01-28 | 9.79 |
| 2026-01-27 | 9.79 |
| 2026-01-26 | 9.79 |
| 2026-01-23 | 10.84 |
| 2026-01-22 | 10.84 |
| 2026-01-21 | 10.84 |
| 2026-01-20 | 11.22 |
| 2026-01-19 | 11.22 |
| 2026-01-16 | 10.72 |
| 2026-01-15 | 10.72 |
| 2026-01-14 | 10.72 |
| 2026-01-13 | 10.72 |
| 2026-01-12 | 10.72 |